Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 351

    1.

    Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.

    Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.

    Diabetes. 2007 Feb;56(2):363-72. Erratum in: Diabetes. 2007 Mar;56(3):897. Takeya, Masahiro [corrected to Takeya, Motohiro]. PMID: 17259380 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.

    Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H.

    Diabetes. 2003 Oct;52(10):2586-93.PMID: 14514644 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.

    Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.

    Diabetes. 2007 Feb;56(2):346-54.PMID: 17259378 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

    J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    7.

    Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

    Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, Breyer MD.

    Diabetes. 2006 Apr;55(4):885-93.PMID: 16567507 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.

    Hamada Y, Fukagawa M.

    Kobe J Med Sci. 2007;53(1-2):53-61.PMID: 17582205 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.

    Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu FT, Di Mario U.

    FASEB J. 2001 Nov;15(13):2471-9.PMID: 11689472 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.

    Lu TC, Wang ZH, Feng X, Chuang PY, Fang W, Shen Y, Levy DE, Xiong H, Chen N, He JC.

    Kidney Int. 2009 Jul;76(1):63-71. Epub 2009 Apr 8.PMID: 19357722 [PubMed - indexed for MEDLINE]Related articles

    11.

    Decorin deficiency enhances progressive nephropathy in diabetic mice.

    Williams KJ, Qiu G, Usui HK, Dunn SR, McCue P, Bottinger E, Iozzo RV, Sharma K.

    Am J Pathol. 2007 Nov;171(5):1441-50. Epub 2007 Sep 20.PMID: 17884968 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.

    Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, Meier M, Gueler F, Fiebeler A, Bahlmann FH, Leitges M, Haller H.

    Diabetes. 2004 Aug;53(8):2101-9.PMID: 15277392 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

    Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.

    Am J Physiol Renal Physiol. 2007 Nov;293(5):F1657-65. Epub 2007 Sep 5.PMID: 17804483 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.

    Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G.

    Diabetes. 2006 Jun;55(6):1642-50.PMID: 16731826 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lack of type VIII collagen in mice ameliorates diabetic nephropathy.

    Hopfer U, Hopfer H, Meyer-Schwesinger C, Loeffler I, Fukai N, Olsen BR, Stahl RA, Wolf G.

    Diabetes. 2009 Jul;58(7):1672-81. Epub 2009 Apr 28.PMID: 19401424 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.

    Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H.

    Diabetologia. 2005 Nov;48(11):2402-11. Epub 2005 Oct 18.PMID: 16231067 [PubMed - indexed for MEDLINE]Related articles

    17.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.

    Daniel C, Schaub K, Amann K, Lawler J, Hugo C.

    Diabetes. 2007 Dec;56(12):2982-9. Epub 2007 Sep 18.PMID: 17878288 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

    Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.

    Diabetes. 2006 Jun;55(6):1678-85.PMID: 16731830 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

    Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H.

    Diabetes. 2004 Jul;53(7):1831-40.PMID: 15220208 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data